You are here: Industry Insights > CDMO

News List

Samsung Biologics and Kineta strike cancer immunotherapy development and manufacturing deal cphi-online
July 22, 2021
Samsung to provide end-to-end CDMO services to advance Kineta's novel anti-VISTA antibody for the treatment of solid tumours
Vetter’s New Clinical Manufacturing Site Now Fully Integrated b3cnewswire
July 22, 2021
A growing number of pharmaceutical and biotech companies are seeking clinical manufacturing partners that provide strategic support and comprehensive resources for their development process of new, promising injectable drug products.
Skyepharma selects Veratrak platform to ensure secure data storing and sharing cphi-online
July 21, 2021
Using Veratrak's platform, the CDMO will have full oversight of data, including an audit trail of data and document processes
Skyepharma Bolsters Data Integrity Capabilities contractpharma
July 21, 2021
CDMO partners with Veratrak to guarantee data integrity for batch manufacturing records.
Thermo Fisher Scientific opens plasmid DNA manufacturing facility at Carlsbad campus cphi-online
July 16, 2021
67,000-square-foot facility at Carlsbad campus is part of CDMO's investment strategy that addresses growing global demand for cell and gene therapies and vaccines
Curia to buy fellow CDMO Integrity Bio cphi-online
July 15, 2021
Acquisition will add West Coast coverage to the CDMO's East Coast and European capabilities and enhance its biologics formulation development and fill-finish network
Recro Pharma Inks Development and Mfg. Pact contractpharma
July 14, 2021
To support a client’s ongoing clinical development of an orally administered, minimally-absorbed investigational compound.
Hochuen Medical Raises Tens of Millions RMB in Series A Financing prnasia
July 13, 2021
Hochuen Medical Technology Co., Ltd. has raised a 40 million Yuan (RMB) Series A round of financing led by Qiming Venture Partners as the sole investor.
AMRI Becomes Curia contractpharma
July 13, 2021
Albany Molecular Research, Inc. (AMRI), a global contract research, development and manufacturing organization serving the pharmaceutical and biopharmaceutical industries, is changing its name to Curia, effective July 12, 2021.
LGM Pharma launches analytical and stability testing as standalone service cphi-online
July 13, 2021
LGM Pharma, a company offering integrated CDMO services, is launching its analytical services and facilities as a standalone contract service for drug developers and manufacturers.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page